3186 results for «3536»
3186 results
Antithrombotic drugs for acute coronary syndromes in women
21 May 2025 – From EuroPCR 2025
Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...
Unconventional situations and complications during cardiovascular interventions
21 May 2025 – From EuroPCR 2025
Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...
LAA closure and anthrombotic therapies
21 May 2025 – From EuroPCR 2025
Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.
How complex left main intervention can be?
21 May 2025 – From EuroPCR 2025
Stay updated on the complexities of left main coronary artery interventions with this comprehensive session. Delve into the latest guidelines and trial data for 2025, understand the meticulous preparation and advanced techniques involved, and examine potential adverse effects and complications through real-world complex case scenarios.
Coronary scaffolds: new developments and applications
21 May 2025 – From EuroPCR 2025
Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.
Mitral TEER in challenging scenarios - Part 2
21 May 2025 – From EuroPCR 2025
This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.
Updates in transcatheter MVR
21 May 2025 – From EuroPCR 2025
This session provides a detailed overview of recent advances in transcatheter mitral valve replacement (TMVR). Examine outcomes from next-generation transcatheter heart valves, long-term clinical data from mitral valve-in-valve and valve-in-ring procedures, and explore innovative approaches including transseptal MVR with insights from global studies.
Imaging-based strategies for complication management in STEMI
21 May 2025 – From EuroPCR 2025
Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
Complication management during mitral TEER procedures
21 May 2025 – From EuroPCR 2025
Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.
TAVI for aortic regurgitation: on-label and off-label use
21 May 2025 – From EuroPCR 2025
This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.
Management of non-culprit lesions in patients with ACS and multivessel disease
21 May 2025 – From EuroPCR 2025
This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
Overcoming resistant lesions in NSTEMI
21 May 2025 – From EuroPCR 2025
Address the challenges of resistant lesions in NSTEMI with this focused session. Learn from complex cases involving thrombus management using Penumbra systems and Guideliner, as well as strategies to overcome extensive calcification through multiple interventional tools, illustrating a stepwise approach to tackling difficult coronary lesions.
How are we going to treat these sick patients presenting with pulmonary embolism?
21 May 2025 – From EuroPCR 2025
Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.
TAVI in challenging anatomical situations
21 May 2025 – From EuroPCR 2025
Delve into the latest advancements in TAVI for challenging anatomical situations. This session features insights from the NORTHOSTAVI registry, transcaval TAVI experiences, early discharge protocols following alternative access, and the application of intravascular lithotripsy to enable safe transfemoral valve replacement.
Best companion's case on rotational atherectomy
21 May 2025 – From EuroPCR 2025
Discover expert approaches to rotational atherectomy guided by intravascular ultrasound (IVUS) in treating severely calcified coronary lesions. This session presents complex cases including high-risk LAD tandem lesions and ostial calcification, showcasing the utility of multi-axis rotablation techniques for safe and effective lesion modification.
Critical limb ischaemia below the knee treatment
21 May 2025 – From EuroPCR 2025
This session focuses on advanced techniques for treating critical limb ischaemia below the knee. Understand how to select wires for antegrade recanalisation, the role and timing of retrograde access, and the potential benefits of drug-coated balloons in below-the-knee angioplasty.
TAV-in-TAV in SAV 3 valves procedures
21 May 2025 – From EuroPCR 2025
Examine the complexities of TAV-in-TAV procedures in degenerated surgical aortic valves (SAV) and TAVI valves. This session discusses cases involving massive aortic regurgitation, lifetime management challenges, and valve-in-valve-in-valve scenarios, providing practical insights into managing multiple valve interventions and associated complications.
